Radical Cystectomy: Comprehensive Management Guide
Primary Indication
Radical cystectomy with urinary diversion is the standard treatment for muscle-invasive bladder cancer (MIBC), with specific indications including T2-T4a disease, high-risk non-muscle invasive disease refractory to intravesical therapy, and extensive papillary disease not manageable by transurethral resection. 1, 2
Pre-operative Assessment and Optimization
Risk Stratification
- Evaluate patient comorbidities, performance status, and fitness for major surgery 3
- Assess renal function, hepatic function, and nutritional status 4
- Cardiac and pulmonary evaluation for high-risk patients 3
Patient Counseling
- Fully inform patients about benefits and potential risks of all urinary diversion options before surgery, with final decisions based on balanced discussion between patient and surgeon 1
- Discuss advantages and disadvantages of open radical cystectomy (ORC) versus robot-assisted radical cystectomy (RARC) to allow proper procedure selection 1
- Educate patients that bladder preservation with tri-modality therapy is an alternative for those desiring bladder preservation or medically unfit for surgery 5
Pre-operative Preparation
- Do not offer preoperative bowel preparation - this practice should be abandoned as it provides no benefit 1, 6
- Optimize nutritional status pre-operatively 4
- Consider pre-habilitation programs to improve surgical outcomes 3
Surgical Approach
Center Selection and Volume
- Select experienced centers performing at least 20 radical cystectomies per hospital per year, prioritizing center experience over specific surgical technique (ORC vs RARC) 1
- Swedish data demonstrates that centralization results in significant reductions in 90-day mortality and reoperation rates 1
Open vs Robotic-Assisted Approach
- Both ORC and RARC are acceptable approaches with equivalent oncologic outcomes 1
- RARC advantages: shorter hospital stay (0.6-1.5 days less in US/UK studies), lower venous thromboembolism rates (OR 0.56), reduced transfusion requirements (0.5 units less blood), improved physical functioning 1
- ORC advantages: shorter operative time (76 minutes less than RARC), shorter hospital stay in some European centers 1
- No differences exist in 90-day complication rates, postoperative ileus, positive surgical margins, overall quality of life, overall survival, or recurrence-free survival at 36 months median follow-up 1
Lymph Node Dissection
- Perform lymph node dissection as an integral part of radical cystectomy 1
- Perform standard lymph node dissection only - extended lymph node dissection does not improve survival and increases morbidity risk 1
- Standard dissection includes: nodal tissue cranially to common iliac bifurcation, ureter as medial border, internal iliac, obturator fossa, and external iliac nodes, with genitofemoral nerves as lateral borders, caudally to circumflex iliac vein and lacunar ligament 1
- Two major RCTs (German LEA trial and US/Canadian SWOG S1011) confirmed extended dissection provides no survival benefit 1
Gender-Specific Considerations
- Perform sexual organ-preserving techniques in eligible women, selecting patients based on absence of tumor in the area to be preserved to avoid positive soft tissue margins 1
Urinary Diversion Options
Contraindications for Orthotopic Neobladder
- Do not offer orthotopic bladder substitute diversion to patients with invasive tumor in the urethra or at the level of urethral dissection 1
- Non-muscle invasive bladder cancer in prostatic urethra or bladder neck is not necessarily a contraindication if patients undergo regular follow-up cystoscopy and urinary cytology 1
Diversion Selection Criteria
- Orthotopic neobladder: optimal for appropriately selected patients desiring elimination of external stoma and preservation of body image without compromising cancer control; requires patient commitment to labor-intensive rehabilitation and ability to perform self-catheterization if necessary 7
- Continent cutaneous reservoir: reasonable alternative when urinary outflow tract tumor involvement prevents orthotopic neobladder; requires obligate self-catheterization 7
- Ileal conduit: fastest, easiest, least complication-prone option; most commonly performed urinary diversion; acceptable and reliable for patients not candidates for continent diversion 7
Peri-operative Management
Intraoperative Measures
- Provide combined general and epidural anesthesia (thoracic level T9-T11) for complete pain control to minimize postoperative ileus 6
- Maintain adequate hydration to prevent hypovolemia, which increases postoperative ileus risk 6
- Avoid routine postoperative nasogastric tubing, as it increases pulmonary complications without benefit 6
Postoperative Care
- Employ "fast track" measurements to reduce time to bowel recovery 1
- Offer pharmacological venous thromboembolism prophylaxis with low-molecular-weight heparin starting the first day after surgery for at least 4 weeks 1
- Provide early postoperative artificial nutrition (both parenteral and enteral via jejunal nutrition cannula) 6
- Median time to return of bowel movements should be 2 days, with regular diet resumption by day 4 6
Enhanced Recovery Protocols
- Implement multimodality perioperative care regimens to minimize postoperative ileus incidence 6
- Monitor for postoperative ileus beyond day 4, which occurs in approximately 17.7% of patients 6
Special Considerations
Palliative Cystectomy
- Consider for unresectable T4b tumors causing severe symptoms (bleeding, pain, urinary obstruction) when radiotherapy fails 1
- Carries high morbidity (30% severe complications) 1
- May perform cystectomy with urinary diversion or diversion alone 1